SOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence

Marta Winiecka-Klimek1,2, Maciej Smolarz1,2, Maciej P Walczak1

  • 1Department of Research and Development, Celther Polska, Lodz, Poland.

Plos One
|November 5, 2015
PubMed

Insights

Directly reprogramming adult cells into neural stem cells (iNSCs) is less effective than differentiation from induced pluripotent stem cells (iPSCs). Directly reprogrammed cells show limited differentiation and senescence, hindering therapeutic use.

Area of Science:

  • Stem Cell Biology
  • Neuroscience
  • Regenerative Medicine

Background:

  • Induced pluripotent stem cells (iPSCs) carry tumorigenic risks, limiting their use in generating induced neural stem cells (iNSCs).
  • Direct reprogramming of somatic cells offers an alternative route to iNSCs, bypassing iPSC generation.

Purpose of the Study:

  • To systematically compare induced neural cells (iNc) generated via direct reprogramming versus iPSC differentiation.
  • To evaluate gene expression, differentiation potential, and proliferation properties of different iNc types.

Main Methods:

  • Direct reprogramming of human fibroblasts using SOX2 (SiNSc-like) or SOX2 and c-MYC (SMiNSc-like).
  • Generation of iNSCs from iPSCs (ebiNSc).
  • Immunocytochemistry, real-time PCR, BrdU incorporation, and SA-β-gal assays for characterization.

Main Results:

  • All iNc types exhibited neuronal differentiation potential; only ebiNSc showed astrocytic differentiation.
  • Direct reprogramming yielded lower efficiency and neuronal formation compared to iPSC differentiation.
  • Directly reprogrammed cells (SiNSc-like, SMiNSc-like) exhibited senescence and limited long-term survival.

Conclusions:

  • Direct reprogramming protocols are currently insufficient for generating fully reprogrammed iNSCs with broad differentiation capacity.
  • Directly reprogrammed iNSCs may be immature or restricted to neuronal progenitors, limiting therapeutic applications.
  • iPSC differentiation remains a more robust method for generating clinically relevant iNSCs.